scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...998015K |
P356 | DOI | 10.1371/JOURNAL.PONE.0098015 |
P932 | PMC publication ID | 4028248 |
P698 | PubMed publication ID | 24845214 |
P5875 | ResearchGate publication ID | 262539052 |
P50 | author | Minoru Yoshida | Q37370114 |
Daisuke Kaida | Q40104435 | ||
P2093 | author name string | Ichiro Takasaki | |
Takayuki Satoh | |||
Mitsunori Koga | |||
Yumi Kawamura | |||
P2860 | cites work | New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action | Q73070075 |
Nucleosomes can form a polar barrier to transcript elongation by RNA polymerase II | Q79326024 | ||
Nature of the nucleosomal barrier to RNA polymerase II | Q81610323 | ||
The in vivo kinetics of RNA polymerase II elongation during co-transcriptional splicing | Q21090175 | ||
Proteomic analysis identifies a new complex required for nuclear pre-mRNA retention and splicing | Q24317157 | ||
A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site | Q24522607 | ||
Pause sites promote transcriptional termination of mammalian RNA polymerase II | Q24548945 | ||
Targeted 'knockdown' of spliceosome function in mammalian cells | Q24556613 | ||
U1 snRNP determines mRNA length and regulates isoform expression | Q24623251 | ||
3' end mRNA processing: molecular mechanisms and implications for health and disease | Q24648650 | ||
The role of chromatin during transcription | Q27860995 | ||
Identification of a regulated pathway for nuclear pre-mRNA turnover. | Q27931532 | ||
The 3' to 5' degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases of the exosome complex | Q27934144 | ||
Nuclear retention of unspliced mRNAs in yeast is mediated by perinuclear Mlp1. | Q27939910 | ||
The spliceosome: design principles of a dynamic RNP machine | Q28131809 | ||
SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase | Q28512917 | ||
U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation | Q29032058 | ||
Elongation by RNA polymerase II: the short and long of it | Q29614529 | ||
Pre-mRNA processing reaches back to transcription and ahead to translation | Q29615045 | ||
Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase II. | Q34252430 | ||
Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors | Q34419716 | ||
Pre-mRNA splicing is a determinant of histone H3K36 methylation | Q35170883 | ||
Processing the message: structural insights into capping and decapping mRNA. | Q36046476 | ||
Extensive degradation of RNA precursors by the exosome in wild-type cells | Q36392961 | ||
Cross-talks between transcription and post-transcriptional events within a 'mRNA factory'. | Q36849100 | ||
The splicing factor SC35 has an active role in transcriptional elongation | Q36952048 | ||
Mechanisms of RNA degradation by the eukaryotic exosome | Q37714460 | ||
NMD: RNA biology meets human genetic medicine | Q37783315 | ||
RNA polymerase II elongation control | Q37992154 | ||
A splicing-dependent transcriptional checkpoint associated with prespliceosome formation. | Q38787111 | ||
Multiple factors in the early splicing complex are involved in the nuclear retention of pre-mRNAs in mammalian cells | Q39471849 | ||
Spliceosome assembly is coupled to RNA polymerase II dynamics at the 3' end of human genes | Q39479568 | ||
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. | Q40104313 | ||
A dual role for BBP/ScSF1 in nuclear pre-mRNA retention and splicing | Q40370412 | ||
MAZ elements alter transcription elongation and silencing of the fibroblast growth factor receptor 2 exon IIIb | Q40559049 | ||
Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A | Q42146150 | ||
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF. | Q42476005 | ||
RNA polymerase backtracking in gene regulation and genome instability | Q42924286 | ||
New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities | Q44729411 | ||
A movie of RNA polymerase II transcription | Q48424870 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e98015 | |
P577 | publication date | 2014-05-20 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | U2 snRNP is required for expression of the 3' end of genes | |
P478 | volume | 9 |
Q27308081 | A Conserved Nuclear Cyclophilin Is Required for Both RNA Polymerase II Elongation and Co-transcriptional Splicing in Caenorhabditis elegans |
Q38712211 | Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1. |
Q36165982 | Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A. |
Q47121434 | Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP. |
Q37225467 | Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation |
Q38749631 | Posttranscriptional mechanisms controlling diurnal gene expression cycles by body temperature rhythms |
Q38935296 | Splicing inhibition decreases phosphorylation level of Ser2 in Pol II CTD. |
Q49866056 | Targeting cleavage and polyadenylation specific factor 1 via shRNA inhibits cell proliferation in human ovarian cancer |
Q37343029 | Temperature regulates splicing efficiency of the cold-inducible RNA-binding protein gene Cirbp |
Search more.